Clinical trial updates

April 2, 2026

Kanexthal

Update: 18 October 2026 No update available. Update: 30 June 2026 Data presented at the EHA Annual Congress (11 – 14 June 2026) showed that: – 44 TDT patients…
Read More »
January 4, 2026

Etavopivat

Read More »
December 22, 2023

SP-420

Read More »
August 21, 2023

CASGEVY™ (gene editing)

Read More »
August 21, 2023

INTERCEPT™ (pathogen inactivation)

Read More »
August 20, 2023

Hemanext ONE®

Read More »
August 20, 2023

Ferriprox®

Read More »
August 20, 2023

Reblozyl®

Read More »
August 18, 2023

ZYNTEGLO™ (gene therapy)

Read More »
July 27, 2023

PYRUKYND® / AQVESME™

Read More »